PAINREFORM LTD. (PRFX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
PRFX currently has 3.04M outstanding shares. with significant dilution risk as 119M authorized shares could dilute existing holders by 3925.1%. The company has significantly diluted shareholders by 351.02% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Jun 22, 2026 |
F-1 filing: The company is registering 7,500,000 ordinary shares for potential issuance under an equity line purchase agreement with YA. |
3M | 120M |
| May 13, 2026 |
F-1 filing: This filing represents an equity line offering where the company may sell up to 2,975,616 advance shares and includes a total of 3,000,000 ordinary shares for resale by the selling shareholder. |
870K | 110M |
| Mar 26, 2026 |
20-F filing | 0.8M shares outstanding |
830K | 110M |
| May 02, 2025 |
F-3 filing: This F-3 filing indicates an offering of up to 3,262,695 ordinary shares by a selling shareholder, consisting of shares and warrants. The company had 1,885,001 ordinary shares outstanding as of April 30, 2025, and anticipates having 4,968,927 shares outstanding after the offering, assuming full exercise of warrants. |
1.9M | 110M |
| Apr 07, 2025 |
20-F filing | 1.5M shares outstanding |
1.5M | 110M |
| Dec 06, 2024 |
F-3 filing: F-3 filing for offering of ordinary shares issuable upon the exercise of warrants by selling shareholders. |
870K | 110M |
| Sep 20, 2024 |
F-3 filing: PAINREFORM LTD. may offer, issue and sell from time to time up to US $50,000,000 of its ordinary shares, including in the form of warrants to purchase ordinary shares, including in the form of subscription rights and a combination of such securities, separately or as units, in one or more offerings. |
2.2M | 110M |
| Aug 27, 2024 |
POS AM filing: The filing is a POS AM filing for the offering of ordinary shares upon exercise of common warrants and placement agent warrants. |
7M | 35M |
| Mar 13, 2024 |
POS AM filing: This is a POS AM filing related to a registration statement for PainReform, Ltd., offering securities with an emphasis on risks outlined in the prospectus. |
1.7M | 40M |
| Feb 29, 2024 |
20-F filing | 1.7M shares outstanding |
1.7M | 40M |
| Jan 12, 2024 |
F-3 filing: This F-3 filing is a registration statement for a shelf offering of common stock by PainReform, Ltd. |
11M | 31M |
| Aug 25, 2023 |
F-1 filing: This is an F-1 filing for PainReform, Ltd. involving the offering of ordinary shares and warrants, with a focus on risk factors and cautionary statements regarding forward-looking information. |
11M | 31M |
| Mar 15, 2023 |
20-F filing | 10.7M shares outstanding |
11M | 31M |
| Mar 16, 2022 |
20-F filing | 10.5M shares outstanding |
10M | 31M |
| Sep 03, 2021 |
POS AM filing: This POS AM filing describes an offering of up to 4,589,019 ordinary shares of PainReform, Ltd., consisting of shares issued to selling stockholders and shares issuable upon the exercise of various warrants. |
10M | 31M |
| Sep 03, 2021 |
F-3 filing: Painreform LTD. may offer, issue and sell from time to time up to US $100,000,000 of our ordinary shares, including in the form of warrants to purchase ordinary shares, including in the form of subscription rights, debt securities and a combination of such securities, separately or as units, in one or more offerings. |
10M | 31M |
| Apr 01, 2021 |
F-1 filing: This F-1 filing registers for resale 2,008,692 ordinary shares consisting of (i) 1,304,346 ordinary shares issued to the selling stockholders pursuant to the March 2021 Private Placement (ii) 652,173 ordinary shares issuable upon the exercise of investor warrants issued in the March 2021 Private Placement, and (iii) 52,173 ordinary shares issuable upon the exercise of placement agent warrants issued in the March 2021 Private Placement. |
10M | 700K |
| Mar 22, 2021 |
POS AM filing: This is a POS AM filing related to the offering of warrants to purchase ordinary shares. |
10M | 0 |
| Mar 18, 2021 |
20-F filing | 8.8M shares outstanding |
8.8M | 0 |